Your browser doesn't support javascript.
loading
Uncovering the mode of action of engineered T cells in patient cancer organoids.
Dekkers, Johanna F; Alieva, Maria; Cleven, Astrid; Keramati, Farid; Wezenaar, Amber K L; van Vliet, Esmée J; Puschhof, Jens; Brazda, Peter; Johanna, Inez; Meringa, Angelo D; Rebel, Heggert G; Buchholz, Maj-Britt; Barrera Román, Mario; Zeeman, Amber L; de Blank, Sam; Fasci, Domenico; Geurts, Maarten H; Cornel, Annelisa M; Driehuis, Else; Millen, Rosemary; Straetemans, Trudy; Nicolasen, Mara J T; Aarts-Riemens, Tineke; Ariese, Hendrikus C R; Johnson, Hannah R; van Ineveld, Ravian L; Karaiskaki, Froso; Kopper, Oded; Bar-Ephraim, Yotam E; Kretzschmar, Kai; Eggermont, Alexander M M; Nierkens, Stefan; Wehrens, Ellen J; Stunnenberg, Henk G; Clevers, Hans; Kuball, Jürgen; Sebestyen, Zsolt; Rios, Anne C.
Afiliación
  • Dekkers JF; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.
  • Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Cleven A; Oncode Institute, Utrecht, the Netherlands.
  • Keramati F; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Wezenaar AKL; Oncode Institute, Utrecht, the Netherlands.
  • van Vliet EJ; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Puschhof J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Brazda P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Johanna I; Oncode Institute, Utrecht, the Netherlands.
  • Meringa AD; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Rebel HG; Oncode Institute, Utrecht, the Netherlands.
  • Buchholz MB; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.
  • Barrera Román M; Oncode Institute, Utrecht, the Netherlands.
  • Zeeman AL; Microbiome and Cancer Division, German Cancer Research Center, Heidelberg, Germany.
  • de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Fasci D; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Geurts MH; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Cornel AM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Driehuis E; Oncode Institute, Utrecht, the Netherlands.
  • Millen R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Straetemans T; Oncode Institute, Utrecht, the Netherlands.
  • Nicolasen MJT; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Aarts-Riemens T; Oncode Institute, Utrecht, the Netherlands.
  • Ariese HCR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Johnson HR; Oncode Institute, Utrecht, the Netherlands.
  • van Ineveld RL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Karaiskaki F; Oncode Institute, Utrecht, the Netherlands.
  • Kopper O; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Bar-Ephraim YE; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.
  • Kretzschmar K; Oncode Institute, Utrecht, the Netherlands.
  • Eggermont AMM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Nierkens S; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Wehrens EJ; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.
  • Stunnenberg HG; Oncode Institute, Utrecht, the Netherlands.
  • Clevers H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.
  • Kuball J; Oncode Institute, Utrecht, the Netherlands.
  • Sebestyen Z; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Rios AC; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Nat Biotechnol ; 41(1): 60-69, 2023 01.
Article en En | MEDLINE | ID: mdl-35879361
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Neoplasias Límite: Humans Idioma: En Revista: Nat Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Neoplasias Límite: Humans Idioma: En Revista: Nat Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos